Psychotherapy to Patients With Primary Breast Cancer - Psycho-social and Survival Outcome From a Randomised Trial
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether an intervention to breast cancer patients including psycho-education and group psychotherapy can enhance quality of life and survival.
| Condition | Intervention |
|---|---|
|
Breast Cancer |
Behavioral: Psychosocial support |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Supportive Care |
| Official Title: | Psychosocial Group Intervention to Patients With Primary Breast Cancer - Psychosocial and Survival Outcome From a Randomised Study |
- Quality of life [ Time Frame: 12 months post intervention ] [ Designated as safety issue: No ]Does Quality of Life enhance among a group of primary breast cancer patients who participate in a psychosocial group intervention compared to a control group of primary breast cancer patients who do not recieve any psychosocial intervention?
- Survival [ Time Frame: 5 years post surgery ] [ Designated as safety issue: No ]Does primary breast cancer patients who participate in a psychosocial intervention survive for longer time compared to a control group of primary cancer patients who do not participate in any intervention?
| Enrollment: | 210 |
| Study Start Date: | January 2004 |
| Study Completion Date: | December 2006 |
| Primary Completion Date: | December 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Psychosocial support |
Behavioral: Psychosocial support
Psycho-social group intervention including patient-education for 6 h per week for 2 weeks and group therapy 2½ h for 8 weeks
Other Name: Patient-education and group therapy
|
| No Intervention: Control group |
Detailed Description:
PURPOSE: This randomized study included patients diagnosed with breast cancer who participated in an intervention including education and group psychotherapy lasting 10 weeks after surgery. The purpose of the study was to enhance Quality of Life, coping and social relations and to support the women when going through treatment. PATIENTS AND METHODS: We randomly assigned 210 patients with primary breast cancer to a control or an intervention group. Patients in the intervention group were offered 2 weekly 6-hour sessions of psycho-education and eight weekly 2-hour sessions of group psychotherapy. Participants and nonparticipants were followed up for QoL, coping and social relations after one, six and twelve months post intervention and on vital status 5 years after surgical treatment.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Eligible patients were 18-70 years of age with stage I-IIIA primary breast cancer
Exclusion Criteria:
- Distant metastasis
- Not speaking or understanding Danish
- Over 71 years
- Other life-threatening diseases
- Brain-damaged
Contacts and Locations| Principal Investigator: | Ellen H Boesen, MSc, Phd | Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 |
| Study Chair: | Christoffer Johansen, DSc (Med) | Institute of Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, DK-2100 |
More Information
No publications provided
| Responsible Party: | Ellen H. Boesen, MSc, PhD, Danish Cancer Society |
| ClinicalTrials.gov Identifier: | NCT01108224 History of Changes |
| Other Study ID Numbers: | Camma 2003 |
| Study First Received: | February 16, 2010 |
| Last Updated: | April 20, 2010 |
| Health Authority: | Denmark: Ethics Committee |
Keywords provided by Danish Cancer Society:
|
Quality of life Coping Social relations Survival Psychotherapy |
Additional relevant MeSH terms:
|
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |
ClinicalTrials.gov processed this record on May 16, 2013